Funding Announcements

"We’ve come a long way from launching our initial product from our living rooms in Edinburgh, to working at a global scale with some of the biggest companies in the world as they fundamentally rethink the way they utilise office space. We established Desana ahead of one of the biggest shifts in working culture for generations, and this unprecedented transition has driven a huge amount of growth for us. But, given the scale of the change in this industry, we believe that there’s still so much more to come."

"This is the most comprehensive validation of our platform thus far. While identifying antibodies to GPCRs has traditionally been a complex and time-intensive process requiring expensive specialist technology and training, we have demonstrated that Antiverse’s drug discovery platform can achieve this in a fraction of the time and cost. GPCRs are commercially interesting targets associated with various indications, and these antibodies offer a path to first in vivo results and can potentially be our first assets. I would like to thank our investors, this funding will enable us to continue to develop these assets in-house with our academic collaborators."

"Businesses are continually up against it to find cost efficiencies, while creating more hybrid working environments for their people. Mobile devices, whether used for calls, messages or video meetings, are an essential tool for doing business. Devyce makes it easier and cheaper for companies to help their people make best use of the devices they already have at their disposal, wherever they are located."

"We spoke to 100+ customer support leaders and most managers listen to at most 10 calls per week. This means companies are losing valuable information about how they can improve their service and product."